Yucatan
Agence de relation média

Home / Clients / Nanobiotix

Nos clients

AFNIC

AfoneMobile

AFSSI

Axway

be angels

BeVolution

BioMarine International Convention

BuzzCity

Capcom

Climpact

Compuware

Curver

Delcath Systems

Easyphone

Eure Expansion

Euromediag

Expertissim

Fatwire

Forum Go West

GE Intelligent Platform

Gunnebo

Horus Pharma

IDIS

Ingenico

Institute of the Arts Barcelona

IRIS PHARMA

Jade-i

JAPAN NEXT

Kioneo

Kodak

LANDesk

Loyalty Expert

MTI Technology

Nanobiotix

ParisMadame

Pharmaleads

PlugMed

Polepharma

Precia Molen

Prix de l’Ingénieur Inventeur-Prix Chéreau Lavet

PTC

Regimbeau

Resto-in

Rockwell Automation

Salmson

Second Sight

Sennheiser Communications

Sharp

SKF

Spamina

STENTYS

Swiss Business Hub France

SYNAPHE

TBM Consulting

Verbatim

Visite-privee.com

Watson Marlow

Wilo Water Management

Nanobiotix

Paris, France, based, Nanobiotix is a nanomedecine company dedicated to the development of new treatments for cancer based on the combined application of nanotechnologies and biotechnologies. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo that was incorporated in 2003 and has been primarily funded by leading European venture capital firms (Matignon Technologies, OTC Asset Management, Cap Decisif, Amorcage Rhone-Alpes, CIC Vizille; Masseran Gestion-CGE).  With the development of numerous new compounds, Nanobiotix's objective is to increase its leading position in nanomedicine field.

Voir les communiqués